Disease Management and Healthcare Utilization in Limited English Proficiency Patients with Cardiovascular Disease

Zara Latif1, Shahzad Hassan2, Alexander Chaitoff3

  • 1Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. Zlatif@mgh.harvard.edu.

PubMed

Insights

Language preference did not affect cardiovascular disease (CVD) management in patients with coronary artery disease (CAD) or heart failure (HF). This study found no significant differences in risk factor control or healthcare use between limited English proficient (LEP) and English-speaking individuals.

Area of Science:

  • Cardiology
  • Public Health
  • Health Disparities

Background:

  • Cardiovascular disease (CVD) is highly prevalent, yet data on management for limited English proficient (LEP) patients are scarce.
  • Understanding CVD risk factor control, disease management, and healthcare utilization in LEP populations is crucial.

Purpose of the Study:

  • To investigate CVD risk factor control, disease management, and healthcare utilization in LEP patients compared to English-speaking patients.
  • To identify disparities in care based on language preference.

Main Methods:

  • Retrospective cohort study using the National Health and Nutrition Examination Survey (NHANES) database (2011-2020).
  • Comparison of medication use, symptom burden, healthcare utilization, and CVD risk factors between LEP and English-speaking patients with coronary artery disease (CAD) or heart failure (HF).
  • Multivariable modeling to assess significant differences between language groups.

Main Results:

  • The study population represented 5.8 million adults with CAD or HF.
  • LEP patients with HF showed higher rates of food insecurity and poverty but no differences in symptom burden, medication use, or healthcare utilization compared to English speakers.
  • No significant differences in CVD risk factor control, symptom burden, medication use, or healthcare utilization were observed between LEP and English-speaking patients with CAD, though LEP patients had lower smoking rates.

Conclusions:

  • Language preference did not appear to impact CVD risk factor control, symptom burden, medication use, or healthcare utilization in patients with CAD or HF.
  • Further research is needed to explore access to care and CVD detection rates in LEP populations.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
307
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
305
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
256
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
323
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
223
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
354